✦ LIBER ✦

Sa1052 Triple Therapy Under Real Life Conditions: Telaprevir (TVR) in Combination With Peginterferon-Alfa-2A Plus Ribavirin (P/R) in NaïVE Patients Infected With Chronic Hepatitis C, Genotype 1. The PAN Study

✍ Scribed by Moog, Gero; Mauss, Stefan; Hueppe, Dietrich; Spengler, Ulrich; Schott, Eckart; Eisenbach, Christoph; Schober, Andreas; Heyne, Renate; Jung, Maria-Christina; Teuber, Gerlinde; Doss, Margareta Frank; Rössle, Martin; Pape, Stefan; Schuchmann, Marcus; Alshuth, Ulrich; Buggisch, Peter

Book ID: 122055391
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 361 KB
Volume: 144
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(13)63650-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sa1041 Triple Therapy Under Real Life Co

Sa1041 Triple Therapy Under Real Life Conditions: Telaprevir (TVR) and Boceprevir (BOC) in Combination With Peginterferon-Alfa-2A Plus Ribavirin (P/R) in Treatment Experienced Patients Infected With Chronic Hepatitis C, Genotype 1. the PAN Study

✍ Moog, Gero; Mauss, Stefan; Hueppe, Dietrich; Spengler, Ulrich; Schott, Eckart; E 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 285 KB

Sa1050 Efficacy of Boceprevir Based Trip

Sa1050 Efficacy of Boceprevir Based Triple Therapy in Combination With Peginterferon-Alfa-2A Plus Ribavirin (P/R) Under Real Life Conditions in Treatment Experienced Patients Infected With Chronic Hepatitis C, Genotype 1: The PAN Study

✍ Moog, Gero; Mauss, Stefan; Hueppe, Dietrich; Spengler, Ulrich; Schott, Eckart; E 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 315 KB

Sa1051 Boceprevir Based Triple Therapy i

Sa1051 Boceprevir Based Triple Therapy in Combination With Peginterferon-Alfa-2A Plus Ribavirin (P/R) Under Real Life Conditions in Treatment NaïVE Patients Infected With Chronic Hepatitis C, Genotype 1: An Interim Analysis At Week 12 After Start of Treatment

✍ Moog, Gero; Mauss, Stefan; Hueppe, Dietrich; Spengler, Ulrich; Schott, Eckart; E 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 646 KB

805 WEEK 4 AND 12 EFFICACY OF TELAPREVIR

805 WEEK 4 AND 12 EFFICACY OF TELAPREVIR (TVR) IN COMBINATION WITH PEGINTERFERON alfa 2a/RIBAVIRIN (P/R) IN TREATMENT EXPERIENCED PATIENTS WITH GT-1 UNDER REAL LIFE CONDITIONS

✍ Christensen, S.; Mauss, S.; Eisenbach, C.; Jung, M.-C.; Roessle, M.; Emke, F.; P 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Randomized, double-blind, placebo-contro

Randomized, double-blind, placebo-controlled study of peginterferon alfa-2a (40KD) plus ribavirin with or without amantadine in treatment-naïve patients with chronic hepatitis C genotype 1 infection

✍ Peter Ferenci; Elisabeth Formann; Hermann Laferl; Michael Gschwantler; Franz Hac 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 182 KB

P1123 RESPONSE-GUIDED THERAPY WITH BOCEP

P1123 RESPONSE-GUIDED THERAPY WITH BOCEPREVIR PLUS PEGINTERFERON ALFA-2a (40KD) AND RIBAVIRIN IN TREATMENT-NAIVE PATIENTS INFECTED WITH HCV GENOTYPE 1: INTERIM RESULTS FROM THE TriCo STUDY

✍ Ferenci, P.; Flisiak, R.; Caruntu, F.A.; Lengyel, G.; Hohmann, M.; Bakalos, G. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 92 KB